[1]
Köşeci, T., Olgun, P., Ata, S., Bayram, E., Sungur, M.A. , Eser, K., Duman, B.B. and Çil, T. 2021. Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel. Medical Science and Discovery. 8, 12 (Dec. 2021), 730–734. DOI:https://doi.org/10.36472/msd.v8i12.646.